Drug Shortage Report for ESOMEPRAZOLE

Last updated on 2023-01-10 History
Report ID 170957
Drug Identification Number 02394839
Brand name ESOMEPRAZOLE
Common or Proper name ESOMEPRAZOLE
Company Name PRO DOC LIMITEE
Market Status MARKETED
Active Ingredient(s) ESOMEPRAZOLE
Strength(s) 20MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 30
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2022-10-03
Estimated end date 2023-01-16
Actual end date 2023-01-09
Shortage status Resolved
Updated date 2023-01-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2925 BOULEVARD INDUSTRIEL
LAVAL, QUEBEC
CANADA H7L 3W9
Company contact information 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2023-01-10 English Compare
v15 2023-01-09 French Compare
v14 2023-01-09 English Compare
v13 2022-12-20 French Compare
v12 2022-12-20 English Compare
v11 2022-11-28 French Compare
v10 2022-11-28 English Compare
v9 2022-11-28 French Compare
v8 2022-11-28 English Compare
v7 2022-10-31 French Compare
v6 2022-10-31 English Compare
v5 2022-10-20 French Compare
v4 2022-10-20 English Compare
v3 2022-10-04 English Compare
v2 2022-10-03 French Compare
v1 2022-10-03 English Compare

Showing 1 to 16 of 16